Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Vibalogics Invests US$150million to Expand Virotherapy Facility in Boston
Vibalogics with an investment of US$ 150 million plans to enter the US region to expand Virotherapy Facility The new facility will be located in Boston
Minaris Regenerative Medicine Opens New Manufacturing Sites in Europe and Asia
Minaris Regenerative Medicine plans to invest US$645 million to open new manufacturing facilities in Asia and Europe This expansion increases the cell and gene manufacturing capabilities
Metrics Expands Manufacturing Facility in North Carolina
Metrics Contract Services Metrics plans to invest US$10 million for the expansion of a novel oral solid dosage manufacturing facility in Greenville, North Carolina
Thermo Fisher Scientific Plans to Expand New Facility in Singapore
Thermo Fisher Scientific Inc, plans to invest US$130 million to expand a new facility in Singapore The expanded sterile filling capacity will be dedicated for developing Therapies and Vaccines
Romark Constructs New Manufacturing Facility in Manati
Romark constructs a new stateoftheart facility located in Manati, Puerto Rico The new manufacturing facility is estimated with an amount of more than US$80 million
Merck Invests US$715 million in New Facility at Madison,USA
Merck with an investment of US$715 million plans for the expansion of Antibodydrug Conjugates ADC manufacturing The new manufacturing facility will be located in Madison, Wisconsin, USA
Luina Bio Expands with New Manufacturing Facilities
Luina Bio plans to expand its new Biomanufacturing GMP and development facility
Eurofins Invests US$169 million to Expand the Chemistry Site in Spain
Eurofins with an investment of US$169 million plans for expansion of the chemistry site for the synthesis of chemicals and purification of drugs The new manufacturing facility will be located in Murcia, Spain
Samsung Biologics Plans to Construct New Manufacturing Facility
Samsung Biologics plans to expand its presence with the construction of a new manufacturing facility located at Incheon
Marker Therapeutics Plans to Construct New Manufacturing Facility in Texas
Marker Therapeutics plans to construct a new manufacturing facility to support clinical development of MultiTAASpecific T cell therapy product candidates The new location will be constructed at Houston, TX, nearby George Bush Intercontinental Airport
